This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Oscar Segurado, MD, PhD
Chief Medical Officer at ASC Therapeutics Inc.


Executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development and medical affairs.

Chief Medical Officer for ASC Therapeutics, formerly for Symvivo, Myriad Genetics-Crescendo and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie (Humira).

Senior medical leader experienced in in gene therapy, immuno-oncology, immuno-therapy, genomics and protein/cell diagnostics, predominantly focused on oncology, hematology and autoimmunity, including personalized medicine, molecular and cellular biomarkers.

 Tenured Professorship of Immunology at the University of Leon, Spain, currently on leave. MD from the University of Salamanca, Spain, and PhD from the University of Wuerzburg, Germany.

Agenda Sessions

  • Hemophilia A Ameliorated in Mice by CRISPR-based In Vivo Genome Editing of Human Factor VIII